Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2014 Financial ResultsGlobeNewswire (Aug 14, 2014)
Capstone Therapeutics Announces Second Quarter 2014 Financial Results and Operating Update Conference CallGlobeNewswire (Aug 6, 2014)
at CNBC.com (Dec 9, 2010)
Thu, Aug. 14, 11:10 AM
Tue, Jun. 24, 10:43 AM
- Under the guise of protecting its accrued tax benefits, Capstone Therapeutics' (CAPS) BOD authorizes and declares a dividend distribution of one right for each share of outstanding common stock. Each right entitles the holder to purchase 1/100 of a share of Series A Preferred Stock for $5.00.
- The plan's intend to to discourage any person from acquiring more than 4.9% of the company's common stock without the approval of the BOD. If an investor were to make an unwanted move to acquire the business and accumulate a 4.9% stake then the rights owners would be eligible to purchase a number of common shares at a 50% discount to the then-current market price.
CAPS vs. ETF Alternatives
Other News & PR